[Hyperhomocysteinemia in acute cerebral infarction]

Rebeca O Millán-Guerrero1, Clemente Vázquez, Lizette Isais-Aguilar

  • 1Servicio de Neurología, Clínica HGZ UMF 1 IMSS, Colima.

Gaceta Medica De Mexico
|October 25, 2003
PubMed

Insights

Elevated homocysteine levels were found in 59% of patients with acute cerebral infarction. This study did not find a link between high homocysteine and common risk factors for stroke.

Area of Science:

  • Neurology
  • Cardiovascular Science
  • Metabolic Disorders

Context:

  • Hyperhomocysteinemia is increasingly implicated in the arteriosclerotic processes underlying cerebral infarction.
  • Understanding homocysteine's role in stroke is crucial for developing targeted interventions.

Purpose:

  • To quantify plasmatic homocysteine levels in patients experiencing acute cerebral infarction.
  • To investigate potential associations between homocysteine levels and clinical stroke subtypes or known risk factors.

Summary:

  • This descriptive study analyzed 22 patients with acute cerebral infarction, measuring serum homocysteine levels.
  • Elevated homocysteine was detected in 59% of patients (13 out of 22), with an average level of 20.68 mumol/l.
  • No significant correlation was identified between hyperhomocysteinemia and clinical stroke characteristics or traditional risk factors like hypertension, diabetes, smoking, or alcoholism.

Impact:

  • The findings highlight a high prevalence of hyperhomocysteinemia in acute cerebral infarction patients.
  • Further research is needed to elucidate the specific factors contributing to elevated homocysteine and to develop strategies for its reduction.
  • Lowering homocysteine levels may offer a novel approach to mitigating cerebrovascular disease incidence.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.